UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: April 4, 2023
Accession Number: 0001193125-23-088041
Submission Type: POS AM
CIK: 0001750149
Company Name: Inhibikase Therapeutics, Inc.
File Number: 333-269521